Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.
Saved in:
| Title: | Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. |
|---|---|
| Authors: | Patterson JR; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA. patte401@msu.edu., Hirst WD; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA, USA., Howe JW; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA.; Neuroscience Program, Michigan State University, East Lansing, MI, USA., Russell CP; Cell and Molecular Biology Department, Grand Valley State University, Allendale, MI, USA., Cole-Strauss A; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA., Kemp CJ; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA., Duffy MF; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA.; Neuroscience Program, Michigan State University, East Lansing, MI, USA., Lamp J; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA., Umstead A; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA., Kubik M; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA.; Neuroscience Program, Michigan State University, East Lansing, MI, USA., Stoll AC; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA., Vega IE; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA., Steece-Collier K; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA., Chen Y; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA, USA., Campbell AC; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA, USA., Nezich CL; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA, USA., Glajch KE; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA, USA., Sortwell CE; Department of Translational Neuroscience, Michigan State University, Grand Rapids, MI, USA.; Neuroscience Program, Michigan State University, East Lansing, MI, USA.; Mercy Health Hauenstein Neuroscience Medical Center, Grand Rapids, MI, USA. |
| Source: | NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 May 24; Vol. 8 (1), pp. 61. Date of Electronic Publication: 2022 May 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2373-8057 |
|---|---|
| DOI: | 10.1038/s41531-022-00322-x |
